Department of Public Health.
Department of Pharmacology.
J Sports Sci Med. 2005 Sep 1;4(3):248-52.
The aim of this study was to determine the rate of doping and performance enhancing drug use in athletes in Sivas, Turkey, and to analyze the main reasons for the use. This was a cross-sectional study based on a self-report questionnaire. The subjects filled the questionnaires under the supervision of the investigators during interviews. This questionnaire included 24 items describing the population in terms of demographics, sport practice, doping in sport and substance use. Moreover, we assessed the frequency of doping drug use. The number of respondents was 883, of which 433 athletes and 450 healthy non-athletes (control group). The mean age of the total volunteers was 21.8 ± 3.7 yrs. The male and female ratios were 78.2% and 21.8% respectively. Doping and performance enhancing drug usage rate was 8.0% (71cases in 883 subjects). Doping drug use among the athletes was significantly (p < 0.05) higher (14.5%) compared with the non-athletes (1.8%). The agents used were anabolic steroids in 60.5%, l-carnitene in 12.7%, erythropoietin in 5.4%, Na-bicarbonate in 11.3% and creatinine in 14.1% of 71 cases. The reasons for doping use were to have a better body condition in 34 cases (47.9%) and to solve weight (gaining or loosing) problems in 8 (11.3%) cases. Since the potential side effects of doping drugs are not satisfactorily familiar to the most users, the education of athletes on the matter must be a top priority. Key PointsDoping and performance enhancing drug use was 71 (8.0%) in 883 subjects, and it was significantly higher (14.5%) in the athletes compared with the non-athletes (1.8%) in Sivas, Turkey.The rate of athletes who experienced such drugs at least once in their life was 29.0%.The 52.4% of doping and performance enhancing drug users accepted that they were unaware of the drugs full and/or potential side effects.
本研究旨在确定土耳其锡瓦斯市运动员的兴奋剂和增强性能药物使用比率,并分析使用的主要原因。这是一项基于自我报告问卷的横断面研究。研究对象在调查员的监督下填写问卷。该问卷包括 24 个项目,从人口统计学、运动实践、运动中的兴奋剂和物质使用方面描述人群。此外,我们评估了兴奋剂药物使用的频率。共 883 名受访者,其中 433 名运动员和 450 名健康非运动员(对照组)。志愿者的平均年龄为 21.8 ± 3.7 岁。男女比例分别为 78.2%和 21.8%。兴奋剂和增强性能药物使用率为 8.0%(883 名受试者中有 71 例)。运动员的兴奋剂药物使用率(14.5%)明显高于非运动员(1.8%)(p < 0.05)。使用的药物有 60.5%的合成代谢类固醇、12.7%的左旋肉碱、5.4%的促红细胞生成素、11.3%的碳酸氢钠和 14.1%的肌酸。71 例中,因改善身体状况而使用兴奋剂的有 34 例(47.9%),因解决体重(增减)问题而使用兴奋剂的有 8 例(11.3%)。由于大多数使用者对兴奋剂药物的潜在副作用并不十分熟悉,因此对运动员进行相关教育必须是当务之急。要点土耳其锡瓦斯市 883 名受试者中,有 71 名(8.0%)使用兴奋剂和增强性能药物,运动员的使用率(14.5%)明显高于非运动员(1.8%)。在运动员中,至少有一次使用过此类药物的比例为 29.0%。52.4%的兴奋剂和增强性能药物使用者承认他们对药物的全部和/或潜在副作用并不了解。